Invention Grant
- Patent Title: Hydroxamate-based inhibitors of deacetylases B
- Patent Title (中): 脱乙酰酶的羟基甲酸酯抑制剂B
-
Application No.: US13082956Application Date: 2011-04-08
-
Publication No.: US08349883B2Publication Date: 2013-01-08
- Inventor: Michael D. Shultz , Christine Hiu-Tung Chen , Young Shin Cho , Lei Jiang , Jianmei Fan , Gang Liu , Dyuti Majumdar , Jianke Li
- Applicant: Michael D. Shultz , Christine Hiu-Tung Chen , Young Shin Cho , Lei Jiang , Jianmei Fan , Gang Liu , Dyuti Majumdar , Jianke Li
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Laura K. Madden
- Main IPC: A61K31/4162
- IPC: A61K31/4162 ; A61K31/4155

Abstract:
The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R1, R2, R3, Y, Z, and are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.
Public/Granted literature
- US20110183964A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B Public/Granted day:2011-07-28
Information query
IPC分类: